Ascendiant Capital Maintains Buy on Synergy CHC, Lowers Price Target to $3.75

Benzinga Newsdesk www.benzinga.com Negative 83.1%

Neg 83.1% Neu 0% Pos 0%

Ascendiant Capital analyst Edward Woo maintains Synergy CHC (NASDAQ:SNYR) with a Buy and lowers the price target from $5.5 to $3.75.